Executives
?
Kenny John P.
Director
Biomerica, Inc.
US, Irvine [HQ]
CIK
1719325
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
109,620
Price per Share :
$33.97
Equivalence :
$3,723,791.40
Transaction History
-
J109,620 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/15/21
-
Footnotes
-
-
Footnotes:#1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.#2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 99,505 on October 1, 2022; and (ii) 56,006 on November 15, 2023.
-
A265,131 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/15/21
-
Footnotes
-
-
Footnotes:#1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.#2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 99,505 on October 1, 2022; and (ii) 56,006 on November 15, 2023.
-
M278,690 Shares After TransactionValue : $2,814,769.00$136,945.90Transaction Date : 06/24/22
-
Footnotes
-
-
Footnotes:#1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.#2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.11. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.#3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.76. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
-
S265,131 Shares After TransactionValue : $7,953,930.00Sold $406,770.00Transaction Date : 06/24/22
-
Footnotes
-
-
Footnotes:#1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.#2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.11. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.#3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.76. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
-
M326,568 Shares After TransactionValue : $3,298,336.80$620,513.70Transaction Date : 06/27/22
-
Footnotes
-
-
Footnotes:#1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021.#2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.11. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.#3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.76. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.